Table 2.
ART adherence and clinical outcomes at baseline, post-treatment and follow-up assessments
| Variable | Baseline assessment | Post-treatment assessment | Follow-up assessment | |||||
|---|---|---|---|---|---|---|---|---|
| PATCH (n = 17) | SRSP (n = 17) | PATCH (n = 15) | SRSP (n = 14) | ES | PATCH (n = 14) | SRSP (n = 14) | ES | |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |||
| Currently taking ART | 16 (94.1%) | 12 (70.6%) | 15 (100%) | 9 (64.3%) | 14 (100%) | 11 (78.6%) | ||
| Difficulty taking ART | 6 (35.3%) | 3 (17.6%) | 4 (26.7%) | 3 (21.4%) | 0.43 | 2 (14.3%) | 2 (14.3%) | 0.54 |
| Missed dose 1 + times per week | 11 (64.7%) | 9 (52.9%) | 2 (13.3%) | 4 (28.6%) | 0.21 | 3 (21.4%) | 4 (28.6%) | 0.50 |
| Viral load > 40 | 8 (61.5%) | 9 (69.2%) | - | - | 4 (33%) | 8 (66.7%) | 0.39 | |
| M (SD) | M (SD) | M (SD) | M (SD) | ES | M (SD) | M (SD) | ES | |
| CD4 count | 388.1 (288.4) | 325 (237.8) | - | - | 498.3 (323.2) | 377.2 (256.8) | 0.35 | |
| Clinic visits | 1.6 (1.6) | 1.8 (2.2) | 0.9 (1.2) | 0.6 (0.9) | 0.24 | 1.8 (2.2) | 2.8 (1.7) | − 0.21 |
Effect size (ES) for category variables calculated as estimated odds ratio, for continuous variables calculated as group-by-time interaction divided by raw standard deviation at baseline